combined treatment [topp]
hypolipemia [patf]
Obesity [dsyn]
Severe [qlco]
Dyslipidaemia [dsyn]
objectives [inpr]
Severe [qlco]
Hyperlipoproteinaemia [dsyn]
Increased LDL [fndg]
Light [npop]
density [qnco]
Lipoproteins [aapp, bacs]
VLDL [lbpr]
Very light [fndg]
density [qnco]
Lipoproteins [aapp, bacs]
Patients [podg]
High [qlco]
Body Mass Index [diap]
Associated [qlco]
occurrence [ftcn]
coronary heart disease [dsyn]
This [euka]
condition [dsyn]
Combined [qlco]
Drug [phsu]
Regimen [topp]
high lipid [fndg]
Level [qlco]
Frequently [tmco]
Diet [food]
Aim [idcn]
Study [mnob]
To [qlco]
investigate [ftcn]
Efficacy [qlco]
Combined therapy [topp]
Following [tmco]
Association [menp]
HMG-CoA Reductase Inhibitors [orch, phsu]
Fibrates [orch, phsu]
Methods [inpr]
Examined [fndg]
Patients [podg]
Males [fndg]
Affected [ftcn]
Obesity [dsyn]
Body Mass Index [diap]
Hyperlipoproteinaemia [dsyn]
Phenotype [orga]
First [qnco]
Group [idcn]
Obese [dsyn]
Subject [grup]
Severe [qlco]
Second [qnco]
Group [idcn]
MILDLY [idcn]
Obese [dsyn]
Patients [podg]
Received [qlco]
Bezafibrate [orch, phsu]
mg% [qnco]
Pravastatin [orch, phsu]
mg/d [qnco]
Subject [grup]
Obese [dsyn]
Highly [qlco]
Dyslipidaemia [dsyn]
Patients [podg]
Received [qlco]
Patients [podg]
Bezafibrate [orch, phsu]
mg% [qnco]
Rest [dora]
mg/d [qnco]
Weekly [tmco]
TEN [dsyn]
weeks [tmco]
Evaluated [ftcn]
Following [tmco]
Serum [bdsu]
Parameters [fndg]
Total Cholesterol [lbpr]
Cholesterol, HDL [bacs, lipd]
Triglycerides [bacs, lipd]
Apolipoprotein A-I [aapp, bacs]
Result [ftcn]
Observed [ftcn]
Cholesterol, HDL [bacs, lipd]
Apolipoprotein [aapp, bacs]
Levels [qlco]
reduction [npop]
Total Cholesterol [lbpr]
Triglycerides [bacs, lipd]
Induced [ftcn]
Combined therapy [topp]
Evidence [ftcn]
Patients [podg]
high lipid [fndg]
Alteration [idcn]
Compared [acty]
Additive [qlco]
Effect [qlco]
Single [popg]
Drugs [phsu]
Conclusions [idcn]
Data [idcn]
Show [inpr]
combined treatment [topp]
PROPOSED [idcn]
Subject [grup]
Hyperlipidaemia [dsyn]
Risk [qlco]
Premature [tmco]
Atherosclerosis [dsyn]
